Clinical Trial

A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants

Name: A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants — clinical trial record (NCT06612970)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The aim of this study is to investigate the safety and tolerability of HB0056 in healthy subjects following single-dose.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-09-23; most recent amendment 2025-09-05.

Status change: Not Yet Recruiting → Recruiting 2025-01-02

Trial Details

NCT Number	NCT06612970
Lead Sponsor	Shanghai Huaota Biopharmaceutical Co., Ltd.
Conditions	Healthy
Enrollment	46 participants
Start Date	2024-11-18
Primary Completion	2025-06-13 (estimated)
Study Completion	2025-10-01 (estimated)
Updated on ClinicalTrials.gov	2025-09-08